<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT942-13217</title>
	</head>
	<body>
		<main>
			<p>940426 FT  26 APR 94 / UK Company News: Anagen cuts loss to Pounds 4m as R&amp;D spending rises Reduced pre-tax losses of Pounds 4.03m were announced by Anagen, the biotechnology company, for the year to December 31 1993. The company, which came to the market via a Pounds 14.3m placing last June, incurred losses of Pounds 5.39m in 1992. R&amp;D expenditure rose from Pounds 3.9m to Pounds 4.32m and Mr Henry Simon, chairman, said the AuraFlex programme had been its main activity in the year. He added that systems were being delivered to several European countries and the company believed its first product was on track to make a significant penetration of the immunodiagnostic market. In the current year, the company would concentrate on new product development and on manufacturing the assay test packs for the AuraFlex system. Turnover grew to Pounds 1.73m (Pounds 238,000). Losses per share were 11p (23.7p).</p>
		</main>
</body></html>
            